Merck & Co. Inc.
04/08/2026 | Press release | Distributed by Public on 04/08/2026 14:29
Additional Proxy Soliciting Materials (Form DEFA14A)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement |
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☒ |
Definitive Additional Materials |
| ☐ |
Soliciting Material Pursuant to Section 240.14a-12 |
Merck & Co., Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required. |
| ☐ |
Fee paid previously with preliminary materials. |
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V90969-P46756-Z92129 *Please check the meeting materials for any special requirements for meeting attendance. MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY, NJ 07065 MERCK & CO., INC. 2026 Annual Meeting Vote by May 25, 2026 11:59 PM ET You invested in MERCK & CO., INC. and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 26, 2026. Vote Virtually at the Meeting* May 26, 2026 9:00 a.m. Eastern Time Virtually at: www.virtualshareholdermeeting.com/MRK2026 Get informed before you vote View the Notice and Proxy Statement and Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 12, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639, or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Merck
Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click "Delivery Settings". Voting Items Board Recommends V90970-P46756-Z92129 1. Election of Directors Nominees: 1a. Douglas M. Baker, Jr. For 1b. Mary Ellen Coe For 1c. Pamela J. Craig For 1d. Robert M. Davis For 1e. Thomas H. Glocer For 1f. Surendralal L. Karsanbhai For 1g. Risa J. Lavizzo-Mourey, M.D. For 1h. Stephen L. Mayo, Ph.D. For 1i. Paul B. Rothman, M.D. For 1j. Patricia F. Russo For 1k. Christine E. Seidman, M.D. For 1l. Inge G. Thulin For 1m. Kathy J. Warden For 2. Non-binding advisory vote to approve the compensation of our named executive officers. For 3. Ratification of the appointment of the Company's independent registered public accounting firm for 2026. For 4. Shareholder proposal regarding a report on DEI risks in federal contracting. Against 5. Shareholder proposal regarding a report on healthcare coverage gaps. Against 6. Shareholder proposal regarding a report on political contributions. Against THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.
Merck & Co. Inc. published this content on April 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on April 08, 2026 at 20:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]